Thomas D. Bannister,William R. Roush,Jun Yong Choi,Reji Nair,Andy S. Tsai,Jitendra K. Mishra,John L. Cleveland
申请号:
US16439950
公开号:
US20190330228A1
申请日:
2019.06.13
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The invention provides compounds that inhibit monocarboxylate transporters, such as MCT1 and MCT4. Compounds of the invention can be used for treatment of a condition in a patient, wherein the condition is characterized by the heightened activity or by the high prevalence of MCT1 and/or MCT4, such as cancer or type II diabetes.